834. Characterization of Heavily Treatment Experienced HIV-1 Infected Clinical Trial Participants Infected with SARS-CoV-2 COVID 19: Fostemsavir BRIGHTE Phase 3 Clinical Trial

Saved in:
Bibliographic Details
Published in:Open forum infectious diseases 2021-12, Vol.8 (Supplement_1), p.S509-S509
Main Authors: Chabria, Shiven, De Wit, Stephane, Pierce, Amy, Shepherd, Bronagh M, Warwick-Sanders, Michael, Du, Fangfang, Wang, Marcia, Clark, Andrew, Ackerman, Peter
Format: Article
Language:English
Subjects:
Poster Abstracts
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2328-8957
2328-8957
DOI:10.1093/ofid/ofab466.1030